Lung Cancer

Our generational commitment to driving scientific innovation is reflected by our robust pipeline of cancer cell-directed and immune-oncology investigational therapies, as well as the smart combination of these approaches. Boehringer Ingelheim is taking a diligent and broad approach, creating a collaborative research network to tap into a diversity of minds, which is vital in addressing some of the most challenging, but potentially most impactful, areas of cancer research.

Keith

Facing Lung Cancer: Keith’s Story

Keith is a lung cancer survivor who took a truly awe-inspiring approach to his recovery journey.

Targeting HER2 mutations in cancer
Woman in lab
Cancer

Targeting HER2 mutations in cancer

Our cancer researchers share insights into the discovery of our investigational HER2-selective tyrosine kinase inhibitor.
Read more
Exploring T-cells in cancer
Lamine Mbow on our approach to Immuno-oncology
Cancer

Exploring T-cells in cancer

Lamine Mbow, our Global Head of Cancer Immunology and Immune Modulation, shares our approach to immuno-oncology highlighting our cancer research and how we are driving innovation to deliver meaningful advances to people with cancer.
Read more